About Elevance Health, Inc.
Elevance Health, Inc. (ELV) has been publicly traded since 2001, making it a 25-year-old public company. It operates in the Healthcare Plans industry within the Healthcare sector. The company is headquartered in Indianapolis, United States and employs approximately 96,129 people. With a market capitalization of $64 billion, ELV is a large established company.
Key Statistics
- Current Price
- $292.42
- Market Cap
- $64.54B
- 52-Week High
- $458.75
- 52-Week Low
- $273.71
- Sector
- Healthcare
- Industry
- Healthcare Plans
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -16.07% | $348.40 | $292.42 |
| 2025 | -3.14% | $359.68 | $348.40 |
| 2024 | -20.72% | $453.68 | $359.68 |
| 2023 | -6.89% | $487.24 | $453.68 |
| 2022 | +11.83% | $435.71 | $487.24 |
| 2021 | +46.12% | $298.19 | $435.71 |
| 2020 | +7.74% | $276.76 | $298.19 |
| 2019 | +16.33% | $237.90 | $276.76 |
| 2018 | +18.11% | $201.42 | $237.90 |
| 2017 | +58.72% | $126.91 | $201.42 |
| 2016 | +5.15% | $120.69 | $126.91 |
| 2015 | +12.87% | $106.93 | $120.69 |
| 2014 | +38.21% | $77.36 | $106.93 |
| 2013 | +54.63% | $50.03 | $77.36 |
| 2012 | -6.29% | $53.39 | $50.03 |
| 2011 | +18.24% | $45.16 | $53.39 |
| 2010 | -2.45% | $46.29 | $45.16 |
| 2009 | +38.36% | $33.46 | $46.29 |
| 2008 | -51.98% | $69.67 | $33.46 |
| 2007 | +11.49% | $62.49 | $69.67 |
| 2006 | -1.38% | $63.37 | $62.49 |
| 2005 | +38.77% | $45.66 | $63.37 |
| 2004 | +53.33% | $29.78 | $45.66 |
| 2003 | +19.24% | $24.98 | $29.78 |
| 2002 | +27.07% | $19.66 | $24.98 |
Valuation
ELV currently trades at a trailing P/E ratio of 11.6, which is considered low relative to the broader market. The forward P/E of 9.9 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 1.5. The price-to-sales ratio is 0.3.
Dividends
Elevance Health, Inc. pays a dividend to shareholders with a current yield of 2.36%. This translates to $6.88 per share annually. The payout ratio of 27% indicates sustainable dividend coverage.
Risk & Volatility
ELV has a beta of 0.47, indicating it is less volatile than the overall market. The stock's 52-week range is $273.71 to $458.75, and it currently trades near its 52-week low.
Analyst Ratings
Based on 20 analyst opinions, ELV has a consensus "buy" rating. The average price target of $380.95 suggests 30.6% upside from current levels.
Frequently Asked Questions
What does Elevance Health, Inc. do? ▼
Elevance Health, Inc. is a Healthcare Plans company operating in the Healthcare sector. The company is headquartered in Indianapolis, United States.
What sector is ELV in? ▼
ELV operates in the Healthcare sector, specifically in the Healthcare Plans industry.
When did ELV go public? ▼
Elevance Health, Inc. went public in 2001, making it a 25-year-old public company as of 2026.
How much would $1,000 invested in ELV 5 years ago be worth today? ▼
A $1,000 investment in ELV five years ago would be worth approximately $940 today, representing a -6.0% return.
Does ELV pay dividends? ▼
Yes, Elevance Health, Inc. pays a dividend with a current yield of 2.36%, which is $6.88 per share annually.
What is ELV's market cap? ▼
Elevance Health, Inc. has a market capitalization of $64 billion, classifying it as a large-cap company.
What is ELV's P/E ratio? ▼
ELV has a trailing P/E ratio of 11.6 and a forward P/E of 9.9, which measures how much investors are paying per dollar of earnings.
Is ELV a buy, hold, or sell? ▼
Based on 20 opinions, ELV has a consensus "buy" rating. The average price target is $380.95.
Last updated: 3/14/2026